TITLE

High Prevalence of Germline CDKN2A Mutations in Slovenian Cutaneous Malignant Melanoma Families

PUB. DATE
December 2006
SOURCE
Croatian Medical Journal;2006, Vol. 47 Issue 6, p851
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
23521936

 

Related Articles

  • BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs. Carbone, Michele; Korb Ferris, Laura; Baumann, Francine; Napolitano, Andrea; Lum, Christopher A.; Flores, Erin G.; Gaudino, Giovanni; Powers, Amy; Bryant-Greenwood, Peter; Krausz, Thomas; Hyjek, Elizabeth; Tate, Rachael; Friedberg, Joseph; Weigel, Tracey; Pass, Harvey I.; Haining Yang // Journal of Translational Medicine;2012, Vol. 10 Issue 1, p179 

    Background: BRCA1-associated protein 1 (BAP1) is a tumor suppressor gene located on chromosome 3p21. Germline BAP1 mutations have been recently associated with an increased risk of malignant mesothelioma, atypical melanocytic tumors and other neoplasms. To answer the question if different...

  • CDKN2A mutations and melanoma risk in the Icelandic population. Goldstein, A. M.; Stacey, S. N.; Olafsson, J. H.; Jonsson, G. .F.; Helgason, A.; Sulem, P.; Sigurgeirsson, B.; Benediktsdottir, K. R.; Thorisdottir, K.; Ragnarsson, A.; Kjartansson, J.; Kostic, J.; Masson, G.; Kristjansson, K.; Gulcher, J. R.; Kong, A.; Thorsteinsdottir, U.; Rafnar, T.; Tucker, M. A.; Stefansson, K. // Journal of Medical Genetics;May2008, Vol. 45 Issue 5, p284 

    Background: Germline CDKN2A mutations have been observed in 20-40% of high risk, melanoma prone families; however, little is known about their prevalence in population based series of melanoma cases and controls. Methods: We resequenced the CDKN2A gene, including the p14ARF variant and promoter...

  • Frequency of UV-inducible NRAS Mutations in Melanomas of Patients With Germline CDKN2A Mutations. Eskandarpour, Malihe; Hashemi, Jamileh; Kanter, Lena; Ringborg, Ulrik; Platz, Anton; Hansson, Johan // JNCI: Journal of the National Cancer Institute;6/4/2003, Vol. 95 Issue 11, p790 

    Background: Germline alterations in cyclin-dependent kinase inhibitor 2A (CDKN2A) are important genetic factors in familial predisposition to melanoma. Activating mutations of the NRAS proto-oncogene are among the most common somatic genetic alterations in cutaneous malignant melanomas. We...

  • Prevalence of variations in melanoma susceptibility genes among Slovenian melanoma families. Peric, Barbara; Cerkovnik, Petra; Novakovic, Srdjan; Zgajnar, Janez; Besic, Nikola; Hocevar, Marko // BMC Medical Genetics;2008, Vol. 9, Special section p1 

    Background: Two high-risk genes have been implicated in the development of CM (cutaneous melanoma). Germline mutations of the CDKN2A gene are found in < 25% of melanoma-prone families and there are only seven families with mutation of the CDK4 gene reported to date. Beside those high penetrance...

  • Melanoma prone families with CDK4 germline mutation: phenotypic profile and associations with MC1R variants. Eknes Puntervoll, Hanne; Xiaohong R. Yang; Høberg Vetti, Hildegunn; Bachmann, Ingeborg M.; Françoise Avril, Marie; Benfodda, Meriem; Catricalà, Caterina; Dalle, Stéphane; Duval-Modeste, Anne B.; Ghiorzo, Paola; Grammatico, Paola; Harland, Mark; Hayward, Nicholas K.; Hui-Han Hu; Jouary, Thomas; Martin-Denavit, Tanguy; Ozola, Aija; Palmer, Jane M.; Pastorino, Lorenza; Pjanova, Dace // Journal of Medical Genetics;Apr2013, Vol. 50 Issue 4, p264 

    Background CDKN2A and CDK4 are high risk susceptibility genes for cutaneous malignant melanoma. Melanoma families with CDKN2A germline mutations have been extensively characterised, whereas CDK4 families are rare and lack a systematic investigation of their phenotype. Methods All known families...

  • POLE mutations in families predisposed to cutaneous melanoma. Aoude, Lauren; Heitzer, Ellen; Johansson, Peter; Gartside, Michael; Wadt, Karin; Pritchard, Antonia; Palmer, Jane; Symmons, Judith; Gerdes, Anne-Marie; Montgomery, Grant; Martin, Nicholas; Tomlinson, Ian; Kearsey, Stephen; Hayward, Nicholas // Familial Cancer;Dec2015, Vol. 14 Issue 4, p621 

    Germline mutations in the exonuclease domain of POLE have been shown to predispose to colorectal cancers and adenomas. POLE is an enzyme involved in DNA repair and chromosomal DNA replication. In order to assess whether such mutations might also predispose to cutaneous melanoma, we interrogated...

  • Somatic BRAF and NRAS Mutations in Familial Melanomas with Known Germline CDKN2A Status: A GenoMEL Study. Zebary, Abdlsattar; Omholt, Katarina; van Doorn, Remco; Ghiorzo, Paola; Harbst, Katja; Hertzman Johansson, Carolina; Höiom, Veronica; Jönsson, Göran; Pjanova, Dace; Puig, Susana; Scarra, Giovanna B; Harland, Mark; Olsson, Håkan; Egyhazi Brage, Suzanne; Palmer, Jane; Kanter-Lewensohn, Lena; Vassilaki, Ismini; Hayward, Nicholas K; Newton-Bishop, Julia; Gruis, Nelleke A // Journal of Investigative Dermatology;Jan2014, Vol. 134 Issue 1, p287 

    The article presents information on a study related to the familial cutaneous malignant melanoma (CMM) the CDKN2A, a tumor suppressor gene on chromosome 9p21, is responsible for which. It informs that the specific founder mutations account for most of the germline CDKN2A alterations in almost...

  • Lack of GNAQ and GNA11 germ-line mutations in familial melanoma pedigrees with uveal melanoma or blue nevi. Hawkes, Jason E.; Campbell, Jennifer; Garvin, Daniel; Cannon-Albright, Lisa; Cassidy, Pamela; Leachman, Sancy A. // Frontiers in Oncology;Jun2013, Vol. 3, p1 

    Approximately 10% of melanoma cases are familial, but only 25-40% of familial melanoma cases can be attributed to germ-line mutations in the CDKN2A - the most significant high-risk melanoma susceptibility locus identified to date. The pathogenic mutation(s) in most of the remaining familial...

  • Primary Melanoma Tumors from CDKN2A Mutation Carriers Do Not Belong to a Distinct Molecular Subclass. Staaf, Johan; Harbst, Katja; Lauss, Martin; Ringnér, Markus; Måsbäck, Anna; Howlin, Jillian; Jirström, Karin; Harland, Mark; Zebary, Abdlsattar; Palmer, Jane M; Ingvar, Christian; Olsson, Håkan; Newton-Bishop, Julia; Hansson, Johan; Hayward, Nicholas; Gruis, Nelleke; Jönsson, Göran // Journal of Investigative Dermatology;Dec2014, Vol. 134 Issue 12, p3000 

    The article presents a study which examines the exhibition of a distinct gene expression pattern by primary melanomas from CDKN2A mutation. Findings reveal that cutaneous malignant melanoma (CMM) from CDKN2A germline mutation carriers do not have a distinct gene expression subtype. Also given...

  • Prise en charge des formes familiales de tumeurs rares : mélanomes familiaux et primitifs multiples. Avril, M.-F.; Bressac-de Paillerets, B.; Demenais, F. // Oncologie;Jun2008, Vol. 10 Issue 6, p411 

    The development of multiple primary melanomas, in a familial setting or in a patient, is rare and is observed in about ten per cent of patients with melanomas. These patients and their families represent high-risk groups for the development of new melanomas, which justifies offering them a...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics